Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000006

Chief Legal Officer sold 1,163 shares at $22.99 ($26,737)

  • Chief Legal Officer acquired 3,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Burns James William · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-05 Exercise or conversion : show line 1 in the form 10b5-1 +3,250 27,499 D
2024-01-09 Sale : show line 2 in the form 10b5-1 −1,163 $22.99 $26,737 26,336 D
Open-market sales · 1,163 sh · avg $22.99 · $26,737

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-05 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −3,250 0 D
Loading xslF345X05/wk-form4_1704835508.xml…